Actavis launches generic fungal drug

Published: July 31, 2007 at 12:59 PM

MORRISTOWN, N.J., July 31 (UPI) -- Actavis said Tuesday it launched its generic version of Ortho-McNeil's anti-fungal treatment, Grifulvin V, in the United States.

Actavis' drug, known as griseofulvin oral suspension, is indicated for the treatment of fungal infections of the skin, fingernails and toenails.

Annual sales of the drug in the United States for the 12 months ending March 2007 totaled approximately $38 million.

Actavis, which is headquartered in Iceland, generates one-third of its sales in the United States. The company plans to file up to 45 abbreviated new drug applications and launch as many as 20 new products this year.

© 2007 United Press International, Inc. All Rights Reserved.
Order reprints



Additional News Stories
NBA: Boston 104, Washington 102 (6 min)
COL BKB: Syracuse 85, Florida 73 (8 min)
NHL: Nashville 4, Columbus 3 (SO) (9 min)
NFL: Cleveland 13, Pittsburgh 6 (10 min)
Raphael drawing sells for $48M (12 min)
NHL: Pittsburgh 3, Montreal 2 (13 min)
NHL: Boston 5, Toronto 2 (14 min)
fark
Another sign the economy is roaring back to life: Opticians can't keep up with the demand for monocles...
And so it begins: Tiger Woods mistress #1, Rachel Uchitel, is in talks to pose for Playboy
Photoshop this man with his dogs
Florida must pay cosmetologist $150/day to cover up tattoos of neo-Nazi while he stands trial for...
Woman charged in grits attack. Unknown hominy laws broken
If you stole the 2400 different ecstasy pills a dutchman painstakingly collected over two decades,...